pyridine-2-carboxaldehyde has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Y; Jia, X; Jiang, M; Li, W; Liang, H; Pang, J; Yang, F | 1 |
| Cheng, Z; Deng, J; He, K; Huang, X; Li, J; Qi, J; Qian, K; Tian, L; Wang, Y; Zheng, Y | 1 |
| Fu, Y; Huang, T; Li, C; Li, S; Liu, Y; Yang, Y; Yuan, Y; Zhang, Q; Zhou, S | 1 |
3 other study(ies) available for pyridine-2-carboxaldehyde and Benign Neoplasms
| Article | Year |
|---|---|
Development of a zinc(II) 2-pyridinecarboxaldehyde thiosemicarbazone complex with remarkable antitumor and antiangiogenic activities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Humans; Neoplasms; Thiosemicarbazones; Zinc | 2023 |
Novel 2-pyridinecarboxaldehyde thiosemicarbazones Ga(III) complexes with a high antiproliferative activity by promoting apoptosis and inhibiting cell cycle.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Gallium; Humans; Models, Molecular; Neoplasms; Pyridines; Structure-Activity Relationship; Thiosemicarbazones | 2017 |
Antitumor activity of a 2-pyridinecarboxaldehyde 2-pyridinecarboxylic acid hydrazone copper complex and the related mechanism.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Copper; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; Hydrazones; Neoplasms; Pyridines | 2015 |